Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AGIO compared with CRNX: revenue, margins and what each company keeps, and the suppliers and customers both name
AGIO
Agios Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
CRNX
Crinetics Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AGIO
Agios Pharmaceuticals, Inc.
vs
CRNX
Crinetics Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AGIO: latest quarter is a loss; flow not drawable. CRNX: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AGIO, solid
CRNX, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AGIO
4
ALNY
Alnylam
supplier
—
Avanzanite Bioscience
unlisted
customer
—
NewBridge Pharmaceuticals FZ-
unlisted
customer
—
Royalty Pharma Investments 2019 ICAV
unlisted
customer
Shared
0
No shared counterparties.
Only CRNX
3
—
SKK
unlisted
customer
—
Loyal
unlisted
customer
—
Sanwa Kagaku Kenkyusho
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
AGIO
Agios Pharmaceuticals, Inc.
Change
30.54
▼
−17.97%
· post 31.22
Mkt cap
$1.8B
Revenue
$45M
Q2 FY26
Revenue
$54M
FY25
CRNX
Crinetics Pharmaceuticals, Inc.
Change
84.97
▲
+0.15%
· post 84.97
Closed
Oct 30 '26
Mkt cap
$509.7M
Revenue
$25M
Q2 FY26
Revenue
$8M
FY25
vs
Compare
Closed
Oct 30 '26
AGIO
Agios Pharmaceuticals, Inc.
vs
CRNX
Crinetics Pharmaceuticals, Inc.
30.54
▼
−17.97%
post 31.22
Price
84.97
▲
+0.15%
post 84.97
$1.8B
Mkt cap
$509.7M
Q2 FY26
$45M
Revenue
$25M
Q2 FY26
FY25
$54M
Revenue
$8M
FY25
Change
Change
AGIO
30.54
▼
−17.97%
vs
CRNX
84.97
▲
+0.15%
Closed
Oct 30 '26